Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Diez Domingo, Javier ^a   Surĩach, Nuria Lara ^b   Alcalde, Natalia Malé ^b   Betegán, Lourdes ^b   Largeron, Nathalie ^a   Trichard, Mélanie ^c  

^a Vaccine Investigation Area   (Spain)

^b IQVIA   (United States)

^c SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; COHORT ANALYSIS; COST OF ILLNESS; FEMALE; GASTROENTERITIS; HUMAN; INFANT; MALE; NEWBORN; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; ROTAVIRUS INFECTION; SPAIN; THEORETICAL MODEL; UTILIZATION REVIEW; VIROLOGY;

CHILD, PRESCHOOL; COHORT STUDIES; COST OF ILLNESS; FEMALE; GASTROENTERITIS; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; MALE; MODELS, THEORETICAL; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SPAIN;

EID: 77955293808     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-469     Document Type: Article

References (56)

1. Rotavirus vaccines - an update. CD Kirkwood J Buttery, Expert Opin Biol Ther 2003 3 97 105 10.1517/14712598.3.1.97 12718734
2. The study of infectious intestinal disease in England: socio-economic impact. JA Roberts P Cumberland PN Sockett J Wheeler LC Rodrigues D Sethi PJ Roderick Infectious Intestinal Disease Study Executive, pidemiol Infect 2003 130 1 11 10.1017/S0950268802007690 (Pubitemid 36231218)
3. Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999-2000. A Gil P Carrasco R Jiménez M San-Martín I Oyagüez A Gonzlez, Vaccine 2004 22 2221 5 10.1016/j.vaccine.2003.11.037 15149780
4. Burden of rotavirus disease in the new European Union. [poster]. T Verstraeten JH Wollenswinkel Van den Bosch, Presented at 23rd ESPID congress, Valencia, Spain 2005
5. Vaccine assessment committee of the Spanish Association of Pediatrícs. Vaccination versus Rotavirus [Spanish]. F Giménez, http://www.vacunasaep.org/ [Accessed 4 June 2009]
6. The role of rotavirus vaccine in children vaccine calendar [Spanish]. F Giménez Snchez F Martinán Torres E Bernaola Iturbe M Baca Cots F de Juan Martín J Díez Delgado M Garcés Snchez JA Gámez Campder J Picazo V Pineda Solas, An Pediatr (Barc) 2006 64 573 7 10.1157/13089923 16792965
7. Global illness and deaths caused by rotavirus disease in children. UD Parashar EG Hummelman JS Bresee MA Miller RI Glass, Emerg Infect Dis 2003 9 565 72 12737740
8. Nosocomial gastroenteritis and asymptomatic rotavirus and astrovirus infection in hospitalized children [Spanish]. E Romn Riechmann I Wilhelmi de Cal ML Cilleruelo Pascual C Calvo Rey ML García García A Snchez-Fauquier, An Pediatr (Barc) 2004 60 337 43 10.1157/13058903 15033111
9. Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom. PK Lorgelly D Joshi M Iturriza Gámara J Gray M Mugford, Epidemiol Infect 2008 136 44 55 17335631
10. Acute rotavirus gastroenteritis: burden of disease and cost of illness among young children in Germany [poster]. T Hammerschmidt B Gartner, Presented at the 7th European ISPOR Congress, Value Health 2004 7 6 762
11. Costs associated with outpatient diarrhoea in infants and toddlers: a nationwide study of the Italian Society of Paediatric Gastroenterology and Hepatology. M Fontana G Zuin P Pancheri FC Fusco A Lambertini R Berni Canani SIGEP Working Group on Intestinal Infections, Dig Liver Dis 2004 36 523 7 10.1016/j.dld.2004.03.012 15334772
12. Burden of paediatric rotavirus gastroenteritis and potential benefits of a universal rotavirus vaccination programme with RotaTeq in France. F Huet N Largeron M Trichard H Miadi-Fargier G Jasso-Mosqueda, Vaccine 2007 25 6348 58 10.1016/j.vaccine.2007.06.015 17629598
13. Burden of paediatric rotavirus gastroenteritis and potential benefits of a universal vaccination programme in Germany [poster]. K Buesch N Ezzat M Trichard N Largeron, Presented at the 10th Annual European Congress, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Dublin 2007
14. Epidemiological and economic impact of routine vaccination of infants against rotavirus gastroenteritis in Germany: a preliminary analysis. [poster]. T Hammerschmidt J Forster HI Huppertz U Heininger R Roos BA Standaert, Presented at the 10th Annual European Congress, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Dublin 2007
15. Evaluating rotavirus vaccination in England and Wales Part II. The potential cost-effectiveness of vaccination. M Jit WJ Edmunds, Vaccine 2007 25 3971 9 10.1016/j.vaccine.2007.02.070 17400341
16. Cost and cost-effectiveness of childhood vaccination against rotavirus in France. H Melliez D Levybruhl PY Boelle B Dervaux S Baron Y Yazdanpanah, Vaccine 2008 26 706 15 10.1016/j.vaccine.2007.11.064 18166250
17. The health and economic burden of rotavirus disease in Belgium. J Bilke P Van Damme F De Smet, Eur J Pediatr 2008 167 1409 19 10.1007/s00431-008-0684-3 18317802
18. Assessing the introduction of universal rotavirus vaccination in the Netherlands. TP Zomer YT van Duynhoven MJ Mangen NA van der Maas H Vennema H Boot HE de Melker, Vaccine 2008 26 3757 64 10.1016/j.vaccine.2008.04.039 18514975
19. An econimic anlisis of rotavirus vaccination in Italy. MD Giammanco MA Coniglio S Pignato G Giammanco, Vaccine 2009 27 3904 3911 10.1016/j.vaccine. 2009.04.002 19446934
20. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. T Vesikari DO Matson P Dennehy P Van Damme M Santosham Z Rodriguez MJ Dallas JF Heyse MG Goveia SB Black HR Shinefield CD Christie S Ylitalo RF Itzler ML Coia MT Onorato BA Adeyi GS Marshall L Gothefors D Campens A Karvonen JP Watt KL O'Brien MJ DiNubile HF Clark JW Boslego PA Offit PM Heaton Rotavirus Efficacy and Safety Trial (REST) Study Team, N Engl J Med 2006 354 23 33 10.1056/NEJMoa052664 16394299 (Pubitemid 43048948)
21. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. N Santos Y Hoshino, Rev Med Virol 2005 15 29 56 10.1002/rmv.448 15484186
22. Cost- effectiveness of rotavirus vaccination in the Netherlands [poster]. R Welte JC Pager YTHP Van Dynhoven MAS De Wit, Presented at 6th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Arlington 2001
23. Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine. AK Takala E Koskenniemi J Joensuu M Mäkelä T Vesikari, Clin Infect Dis 1998 27 272 82 10.1086/514650 9709876
24. WHO Coverage rate for DTP. http://www.euro.who.int Accessed 13 September 2006
25. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: The REVEAL Study. P Van Damme C Giaquinto F Huet L Gothefors M Maxwell M Van der Wielen REVEAL Study Group, J Infect Dis Suppl 2007 195 Suppl 1 4 S16 10.1086/516714 17387650
26. Costs of Community-Acquired Pediatric Rotavirus Gastroenteritis in 7 European Countries: The REVEAL Study. C Giaquinto P Van Damme F Huet L Gothefors M Van der Wielen REVEAL Study Group, J Infect Dis Suppl 2007 195 36 44 10.1086/516716 (Pubitemid 46649604)
27. INE, Spanish Institute of Statistics. http://www.ine.es Accessed February 2006
28. Spanish UNICEF statisticshttp://www.unicef.org/spanish/statistics/index- countrystats.html Accessed June 2009
29. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. O Gleizes U Desselberger V Tatochenko C Rodrigo N Salman Z Mezner C Giaquinto E Grimprel, Pediatr Infect Dis J 2006 25 1 Suppl 12 21 16397425
30. Acute viral gastroenteritis: proportion and clinical relevance of multiple infections in Spanish children. E Roman I Wilhelmi J Colomina,, et al. J Med Microbiol 2003 52 435 40 10.1099/jmm.0.05079-0 12721321
31. Incidencia y costes de la hospitalizacián por bronquiolitis y de las infecciones. J Diez-Domingo M Ridao I Ubeda A Ballester, An Ped (Barc) 2006 65 325 30 10.1157/13093515 (Pubitemid 44860163)
32. Burden of rotavirus disease in European Union countries. M Soriano-Gabarrá J Mrukowicz T Vesikari T Verstraeten, Pediatr Infect Dis J 2006 25 1 Suppl 7 S11 16397431
33. Epidemiological and burden of rotavirus diarrhoea in day care centres in Lyon, France. D Floret B Lina S Pinchinat G Billaud F At-Belghiti N Largeron B Bellemin CN Trang C Fau C Gaspard V Mamoux L Marcelon, Eur J Pediatr 2006 165 905 6 Epub 2006 Aug 10. Erratum in: Eur J Pediatr 2008, 167 :255-6 10.1007/s00431-006-0187-z 16900310
34. Diversity of group A human rotavirus types circulating over a 4-year period in Madrid, Spain. A Snchez-Fauquier I Wilhelmi J Colomina E Cubero E Roman, J Clin Microbiol 2004 42 1609 13 10.1128/JCM.42.4.1609-1613.2004 15071013
35. Rotavirus gastroenteritis among children under five years of age in Valencia, Spain. J Díez-Domingo IO Martín AB Sanz AG Lápez CC Martínez CP Boronat MJ Del Barrio DG García MM Pons VA Crespo PA Esteve IL Arfella IS Monrabal LB Baveira MG Lápez, Pediatr Infect Dis J 2006 25 455 7 10.1097/01.inf.0000217378.30444.21 16645514
36. A pharmacoeconomic evaluation of seven-valent pneumococcal conjugate vaccine in Spain. F Asensi M De Jose M Lorente F Moraga V Ciuryla S Arikian R Casciano M Vento, Value Health 2004 7 36 51 10.1111/j.1524-4733.2004.71263.x 14720129
37. Economic evaluation of varicella vaccination in Spain-results from a dynamic model. X Lenne J Diez Domingo A Gil M Ridao JA Lluch B Dervaux, Vaccine 2006 24 6980 9 10.1016/j.vaccine.2006.04.051 16860909
38. Eine prospektive nationale Multizenterstudie zur Bedeutung von Rotaviruserkrankungen in Deutschland. J Forster HD Frank H Henker K Stehr C Rieger, Monatsschr Kinderheilkd 1999 Suppl 2 148
39. How does Italy compare? OECD: Selection of OECD Social Indicators, http://www.oecd.org/dataoecd/35/2/34555477.xls [homepage on the Internet]. Accessed June 2009
40. BOT - Spanish General Council of the Official Colleges of Pharmacists. [CD-ROM] 2006
41. Health Care Costs Database. R Gisbert M Brosa, SOIKOS Version 2.2 2005
42. Economical information System, regional health care ministry (Valencia).
43. INE (Spanish Statististic Institute), ndice de Costes Laborales (2002). [base de datos de Internet]. Madrid. http://www.ine.es Accessed June 2009
44. Labour costs in Europe 1996-2002. HJ Mittag, Brussels: Eurostat; European Communities 2004
45. BOE (Spanish Central Government Official Bulletin), 3/12/05, n° 289. Spanish Treasury, Orden EHA/3770/2005. Sec 1:39852
46. Burden of hospitalizations attributable to rotavirus infection in children in the Autonomous Region of Madrid, Spain, period 1999-2000 [Spanish]. A Gil de Miguel P Carrasco J Esteban M San-Martín A Gonzlez, An Pediatr 2006 4 530 5 10.1157/13089917 (Pubitemid 44133199)
47. Rotavirus vaccines- an update. CD Kirkwood J Buttery, Expert Opin Biol Ther 2003 3 97 105 Review 10.1517/14712598.3.1.97 12718734
48. Primary care-based surveillance to estimate the burden of rotavirus gastroenteritis in European children aged 5 years. C Gianquinto J Díez Domingo Jose-Maria Baldo P Pazdiora J Forster M Patrzalek,, et al. Excellence in Paediatrics, EIP Florence Italy 2009
49. Estimating the incidence of symptomatic rotavirus infections. A systematic review with meta-analysis. J Bilcke P Van Damme M Van Ranst N hens M Aerts P Beutels, PLoS One 2009 4 June(6) 6060 10.1371/journal.pone.0006060 19557133
50. An estimation of indirect costs caused by acute rotavirus gastroenteritis in a Galician area, Spain. F Martinán-Torres M Bouzán-Alejandro M Lápez-Sousa L Redondo-Collazo S Almeida-Agudín C Astorgano-Fernndez JM Martinán-Snchez, Eur J Pediatr 2008 167 337 9 10.1007/s00431-007-0466-3 17364172
51. Cost-effectiveness analysis of a rotavirus immunization programme for the United Status. AW Tucker AC Haddix JS Bresee RC Holman UD Parashar RI Glass, JAMA 1998 279 1371 6 10.1001/jama.279.17.1371 9582045
52. Cost-effectiveness of infant vaccination with Rotarixin the UK. [poster]. A Martin B Stantaert, Presented at the 25th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), Porto, Portugal 2007
53. Debate on vaccine. Varicella and pneumococcal massive immunization could mean a saving for the Health Authority of Spain [Spanish]. A Martín, Rev Esp Econ Salud 2005 4 18 20
54. Decline in rotavirus cases in the U.S. after licensure of a live, oral rotavirus vaccine [abstract]. JM Lieberman X Huang E Koski H Kaufman R Furlanetto H Hurwitz P Ragothaman M Green, 48th Annual ICAAC/IDSA 46th Annual Meeting Washington DC USA 2008 1 437 abstr
55. Post-licensure effectiveness of Rotateq in preventing gastroenteritis in the US [abstract]. TC Mast FT Wang V Goli J Loughlin M Bulotsky JS and Seeger, 48th Annual ICAAC/IDSA 46th Annual Meeting. Washington DC USA 2008 1 433 abstr
56. The cost-effectiveness of rotavirus vaccination: Comparative analises for five European countries and transferability in Europe. M Jit J Bilcke MJJ Mangen H Salo H Melliez WJ Edmunds Y Yazdan P Beutels, Vaccine 2009 27 6121 6128 10.1016/j.vaccine.2009.08.030 19715781